Trupanion Inc

Trupanion’s pet‑insurance stock trades near its $30‑$58 range, with a $1.37B cap and P/E of 19.99—ideal for investors seeking exposure to the growing animal‑health market.

Trupanion Inc. has reported a 124% surge in Q2 profit, exceeding expectations and prompting analysts to raise its stock price target to $67.

Trupanion Inc. projects $1.425 billion in revenue for 2025, driven by strong Q1 performance and improved retention rates, positioning the pet health insurance provider for continued growth.

Trupanion Inc. has demonstrated resilience and innovation in the pet health insurance market, with a strong financial performance and strategic vision positioning it for continued growth and success.